Supplementary Materials

This PDF file includes:

  • Fig. S1. Effect of vedolizumab administration on immunological and virological parameters.
  • Table S1. List of adverse events.
  • Table S2. Comparison of baseline CD4+ T cell counts and percentages of CD38+HLA-DR+CD8+ T cell between participants who met ART restart criteria before or after week 26 of analytical treatment interruption.
  • Study protocol

[Download PDF]